OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Biomolecular Structure & Dynamics is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Unearthing the inhibitory potential of phytochemicals from Lawsonia inermis L. and some drugs against dengue virus protein NS1: an in silico	88
Interfacing manganese-based carbonaceous nanocomposites with plasma components: insights on protein interaction, structure and opsonization	77
Insights into dynamic changes in ADC-7 and P99 cephalosporinases using small angle x-ray scattering (SAXS)	73
Switchable tetraplex elements in the heterogeneous nuclear ribonucleoprotein K promoter: micro-environment dictated structural transitions of G/C rich elements	62
Computational analysis of structural and functional evaluation of the deleterious missense variants in the human CTLA4 gene	56
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)	51
Structural analysis of human ATE1 isoforms and their interactions with Arg-tRNA _Arg	49
Structural and molecular investigation of the impact of S30L and D88N substitutions in G9R protein on coupling with E4R from Monkeypox virus (MPXV)	48
Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines	47
Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs	46
Design, dynamic docking, synthesis, and in vitro validation of a novel DNA gyrase B inhibitor	41
A comprehensive examination of ACE2 receptor and prediction of spike glycoprotein and ACE2 interaction based on in silico analysis of ACE2 receptor	41
The promising impact of Bemcentinib and Repotrectinib on sleep impairment in Alzheimer’s disease	40
Synthesis, structural, characterization, antibacterial and antibiotic modifying activity, ADMET study, molecular docking and dynamics of chalcone ( E )-1-(4-aminophenyl)	39
A simulation-based approach to target Zika virus RNA-dependent RNA polymerase with marine compounds for antiviral development	39
In silico screening of dicoumarols as potential Mur B enzyme inhibitors in Mycobacterium tuberculosis	38
Structural basis of multi-target interactions of Henna Dye Lawsone: an experimental and theoretical evaluation	38
In silico studies for improving target selectivity of anti-malarial dual falcipain inhibitors vis-à-vis human cathepsins	37
Using integrated bioinformatics, network pharmacology and molecular docking to explore the mechanisms underlying the antidepressant effect of celastrol	36
Molecular insights to the anti-COVID-19 potential of α-, β- and γ-cyclodextrins	36
Correction	35
Computational structure-guided approach to simulate delamanid and pretomanid binding to mycobacterial F420 redox cycling proteins: identification of key determinants of resistance	35
Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept	35
In silico analysis of identified molecules using LC–HR/MS of Cupressus sempervirens L. ethyl acetate fraction against three monkeypox virus targets	35
Identification of potent inhibitors targeting Tribolium castaneum GSTe2 via structure-based screening and molecular dynamics simulation	35

Correction	35
Immunoinformatics-driven approach for development of potential multi-epitope vaccine against the secreted protein FlaC of Campylobacter jejuni	35
Crystallographic mining driven computer-guided approach to identify the ASK1 inhibitor likely to perturb the catalytic region	34
Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies	34
In silico designed microtubule-stabilizer drugs against tauopathy in Alzheimer’s disease	33
Harnessing allosteric inhibition: prioritizing LIMK2 inhibitors for targeted cancer therapy through pharmacophore-based virtual screening and essential molecular dynamics	32
iHBPs-VWDC: variable-length window-based dynamic connectivity approach for identifying hormone-binding proteins	31
A reverse docking approach to explore the anticancer potency of natural compounds by interfering metastasis and angiogenesis	31